Page 10 - CJO_F17_GLAUCOMA_SUPPLEMENT
P. 10

C  CLINICAL RESEARCH




               Table 1: Comprehensive Glaucoma Evaluation – Recommendations for Testing


                        Exam Element              Critical Criteria/Testing
                        History
                                                  Investigation of systemic risk factors
                                                  Medical history
                                                  Medications (investigate possible contraindications and cautions for
                                                  glaucoma medications)
                                                  Allergies to medications

                                                  Family history (medical and ocular)
                        Clinical Examination
                                                  Best corrected visual acuity (VA)
                                                  Pupillary function; check for relative afferent defect
                                                  Slit lamp examination of lids, ocular surface integrity, anterior cham-
                                                  ber, lens
                                                  Applanation tonometry (including time measured)

                                                  Blood pressure
                                                  Pachymetry
                                                  Gonioscopy
                                                  Dilated examination of: lens, ONH, RNFL, posterior pole, peripheral
                                                  retina
                        Ancillary Testing
                                                  Automated perimetry 24-2
                                                  Automated perimetry 10-2
                                                  Documentation of ONH/RNFL with fundus photos
                                                  Objective imaging of ONH, RNFL, and macula (most commonly
                                                  with OCT)
                        Follow-up
                                                  Follow-up and management recommendations clearly communicated



               CASE HISTORY
               A comprehensive assessment includes an investigation for concomitant medical conditions that might influence the
               diagnosis of disease. This may include the identification of systemic risk factors or prior conditions that increase the
               risk of POAG, or suggest a secondary or angle closure etiology. Attention should also be paid to any medical condi-
               tions that might impact treatment decisions such as allergies to certain medications or contraindications to the use of
               certain medications (including asthma, chronic obstructive pulmonary disease, or anterior segment inflammation).

               IDENTIFICATION OF RISK FACTORS
               Identification of risk factors is an important part of the diagnosis and management of POAG. Clinically, it may take
               years to confirm structural damage or functional loss, so a diagnosis or management decision may be based on iden-
               tifying strong risk factors for the development or progression of POAG. 56,57  Because of this, there is an increasing ap-
               preciation for the importance of a thorough risk assessment as part of the comprehensive glaucoma work-up, with
               the goal of recognizing individuals who are at higher risk of progressing to functional vision loss and minimizing its
               subsequent impact on overall quality of life.
                                                 42



      10             CANADIAN JOURNAL of OPTOMETRY    |    REVUE CANADIENNE D’OPTOMÉTRIE    VOL. 79  SUPPLEMENT 1, 2017
   5   6   7   8   9   10   11   12   13   14   15